Who owns MYMD PHARMACEUTICALS INC COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Mymd Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Mymd Pharmaceuticals stock

Who bought or sold MYMD PHARMACEUTICALS INC COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Morgan Stanley 192k $24k 100% Jun 2025
 View chart
Advisor Group Holdings 99.00 $2.999700 0% Sep 2025
 View chart
Legacy Investment Solutions 60.00 $7.998000 100% Jun 2025
 View chart

Who sold out of Mymd Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
UBS Group Jun 2025 65k $8.0k
Two Sigma Securities Jun 2025 51k $6.2k
Change Path Jun 2025 41k $5.0k
Jane Street Jun 2025 35k $4.3k
Geode Capital Management Jun 2025 24k $2.9k
Cubist Systematic Strategies Jun 2025 22k $2.7k
Key Client Fiduciary Advisors Jun 2025 20k $2.5k
Vanguard Group Jun 2025 14k $1.7k
Intl Fcstone Jun 2025 12k $1.5k
Tower Research Capital Jun 2025 5.0k $619.894400
BlackRock Jun 2025 3.8k $467.008400
Raymond James Financial Jun 2025 368.00 $45.006400
Group One Trading Jun 2025 324.00 $40.014000
Jones Financial Companies, L.L Jun 2025 201.00 $26.009400
Wells Fargo & Company Jun 2025 167.00 $20.991900
Bryn Mawr Trust Jun 2025 134.00 $15.999600
Union Bankshares Jun 2025 116.00 $14.998800
Hanson McClain Advisors Jun 2025 67.00 $8.998100
Legacy Wealth Managment Jun 2025 60.00 $7.998000